[144] Genpact LTD SEC Filing

Rhea-AI Filing Summary

Genpact Ltd. filing a Form 144 shows a proposed sale of 76,902 common shares, with an aggregate market value of $3,274,240.31, to be executed approximately on 09/12/2025 on the NYSE. The broker listed is Morgan Stanley Smith Barney LLC. The filing itemizes how the securities were acquired: 26,902 performance shares granted on 01/10/2022 and 50,000 shares from a stock option exercise on 09/12/2025 paid in cash. The filing reports nothing to report for securities sold during the past three months. The signer attests they have no undisclosed material adverse information about the issuer.

Positive

• Full transaction details provided including acquisition dates, types, and payment method for the exercised shares
• Broker and exchange disclosed (Morgan Stanley Smith Barney LLC on NYSE)
• No sales reported in the past three months, as explicitly stated

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine insider sale notice with acquisition details and broker disclosure; no prior recent sales reported.

The Form 144 is a standard notice under Rule 144 detailing a proposed sale of 76,902 Genpact common shares via Morgan Stanley Smith Barney LLC on the NYSE. It clearly separates the lots by acquisition type and dates, noting performance shares (01/10/2022) and option exercise (09/12/2025) with cash payment for the exercised portion. The filing also states there were no related sales in the past three months and includes the required attestation regarding undisclosed material information. From a compliance standpoint, the form contains the expected elements to support a Rule 144 sale filing.

Securities Market Analyst

TL;DR: Small, disclosed insider sale; unlikely to be material to Genpact's market capitalization.

The notice documents a proposed sale valued at $3.27 million executed through an institutional broker. The filing provides acquisition dates and payment method for the exercised options, which helps market participants understand the origin of the shares. There are no indications of accelerated or repeated sales disclosed in this filing. Absent additional context about the seller's identity or larger trading plans, this appears to be an isolated, routine disposition rather than a signal of company-level issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	76902	3274240.31	174270076	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2022	Performance Shares	Issuer			26902	01/10/2022	Not Applicable
Common	09/12/2025	Stock Option Exercise	Issuer			50000	09/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Genpact's (G) Form 144 disclose?

The filing discloses a proposed sale of 76,902 common shares with aggregate market value $3,274,240.31, to be sold on 09/12/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

How were the shares in the Genpact (G) Form 144 acquired?

The filing lists 26,902 performance shares acquired on 01/10/2022 and 50,000 shares from a stock option exercise on 09/12/2025, with the exercised shares paid in cash.

Were any Genpact (G) shares sold by this person in the past three months?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale in the Form 144?

The listed broker is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filer attest to possession of material nonpublic information?

Yes. The signer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.